PDT Partners’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.51M | Sell |
69,533
-100
| -0.1% | -$3.6K | 0.14% | 256 |
|
|
2025
Q1 | $2.17M | Buy |
69,633
+100
| +0.1% | +$3.11K | 0.15% | 233 |
|
|
2024
Q4 | $1.77M | Buy |
69,533
+38,599
| +125% | +$985K | 0.16% | 233 |
|
|
2024
Q3 | $875K | Sell |
30,934
-20,502
| -40% | -$580K | 0.08% | 396 |
|
|
2024
Q2 | $1.36M | Buy |
+51,436
| New | +$1.36M | 0.13% | 281 |
|
|
2024
Q1 | – | Sell |
-121,059
| Closed | -$3.4M | – | 680 |
|
|
2023
Q4 | $3.4M | Buy |
121,059
+12,600
| +12% | +$354K | 0.38% | 58 |
|
|
2023
Q3 | $2.94M | Buy |
108,459
+74,037
| +215% | +$2.01M | 0.37% | 71 |
|
|
2023
Q2 | $1.06M | Sell |
34,422
-7,978
| -19% | -$245K | 0.15% | 240 |
|
|
2023
Q1 | $1.53M | Buy |
+42,400
| New | +$1.53M | 0.21% | 176 |
|